MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.
Kanagasabai T, Li G, Shen TH, Gladoun N, Castillo-Martin M, Celada SI, Xie Y, Brown LK, Mark ZA, Ochieng J, Ballard BR, Cordon-Cardo C, Adunyah SE, Jin R, Matusik RJ, Chen Z.
Kanagasabai T, et al. Among authors: adunyah se.
Cancer Lett. 2022 Jan 28;525:46-54. doi: 10.1016/j.canlet.2021.09.041. Epub 2021 Oct 2.
Cancer Lett. 2022.
PMID: 34610416